Literature DB >> 24950941

Management of bleeding liver tumors.

B Darnis1, A Rode2, K Mohkam3, C Ducerf3, J-Y Mabrut3.   

Abstract

Liver tumors bleed rarely; management has changed radically during the last 20years, advancing from emergency surgery with poor results to multidisciplinary management. The first steps are the diagnosis and control of bleeding. Abdominopelvic CT scan should be performed as soon as patient hemodynamics allow. When active bleeding is visualized, arterial embolization, targeted as selectively as possible, is preferable to surgery, which should be reserved for severe hemodynamic instability or failure of interventional radiology. When surgery is unavoidable, abbreviated laparotomy (damage control) with perihepatic packing is recommended. The second step is determination of the etiology and treatment of the underlying tumor. Adenoma and hepatocellular carcinoma (HCC) are the two most frequently encountered tumors in this context. Liver MRI after control of the bleeding episode generally leads to the diagnosis although sometimes the analysis can be difficult because of the hematoma. Prompt resection is indicated for HCC, atypical adenoma or lesions at risk for degeneration to hepatocellular carcinoma. For adenoma with no suspicion of malignancy, it is best to wait for the hematoma to resorb completely before undertaking appropriate therapy.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bleeding; Hepatic adenoma; Hepatocellular carcinoma; Liver tumors; Surgery

Mesh:

Year:  2014        PMID: 24950941     DOI: 10.1016/j.jviscsurg.2014.05.007

Source DB:  PubMed          Journal:  J Visc Surg        ISSN: 1878-7886            Impact factor:   2.043


  9 in total

1.  Efficacy and prognostic factors of transarterial embolization as initial treatment for spontaneously ruptured hepatocellular carcinoma: a single-center retrospective analysis in 57 patients.

Authors:  Chun Zhou; Qing-Quan Zu; Bin Wang; Chun-Gao Zhou; Hai-Bin Shi; Sheng Liu
Journal:  Jpn J Radiol       Date:  2018-12-03       Impact factor: 2.374

2.  Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons' Perspective.

Authors:  Paulo Herman; Gilton Marques Fonseca; Jaime Arthur Pirola Kruger; Vagner Birk Jeismann; Fabricio Ferreira Coelho
Journal:  J Gastrointest Surg       Date:  2020-07-14       Impact factor: 3.452

3.  Treatment of Hepatic Adenomatosis.

Authors:  Claire Meyer; Mauricio Lisker-Melman
Journal:  Curr Hepatol Rep       Date:  2015-05-02

4.  Long-term outcomes of resection in patients with symptomatic benign liver tumours.

Authors:  Belle V van Rosmalen; Matthanja Bieze; Marc G H Besselink; Pieter Tanis; Joanne Verheij; Saffire S K S Phoa; Olivier Busch; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-08-21       Impact factor: 3.647

5.  A giant spontaneous subcapsular hematoma of the liver revealing a COVID-19 infection, a coincidence? (A case report).

Authors:  Anisse Tidjane; Amel Laredj; Nabil Boudjenan-Serradj; Salim Bensafir; Benali Tabeti
Journal:  Pan Afr Med J       Date:  2021-02-08

Review 6.  Hepatocellular carcinoma rupture following transarterial chemoembolization.

Authors:  Nimarta Singh Bhinder; Steven M Zangan
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

Review 7.  Hepatocellular adenoma: An update.

Authors:  Adarsh Vijay; Ahmed Elaffandi; Hatem Khalaf
Journal:  World J Hepatol       Date:  2015-11-08

8.  Transcatheter arterial embolization for hemorrhagic rupture of a simple hepatic cyst: A case report.

Authors:  Toru Imagami; Satoru Takayama; Yohei Maeda; Masaki Sakamoto; Hisanori Kani
Journal:  Radiol Case Rep       Date:  2021-06-08

9.  Treatment outcomes of spontaneous rupture of hepatocellular carcinoma with hemorrhagic shock: a multicenter study.

Authors:  Feng Zhong; Xin-Sheng Cheng; Kun He; Shi-Bo Sun; Jie Zhou; Hai-Ming Chen
Journal:  Springerplus       Date:  2016-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.